ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bi...
做生命科学投资的同学一定都知道基因检测龙头$Illumina(ILMN)$7年15倍的传奇故事,错过的一定后悔不已。现在有更好的机会就在眼前,看看我们是否能抓住了! 7年15倍,多么惊艳的曲线-- ILMN 在创立ILMN对基因检测技术革命后,抱着要对作为生命基础的蛋白质检测技术进行革命的使命,12年前ILMN的创始人之一技术大拿David ...
The current level reflects an upward revision of 54.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period. Ahead of a company's earnings discl...
which include stock-based compensation. I encourage you to review the GAAP reconciliation of these non-GAAP measures, which can be found in today’s release and in supplementary data available on our website. In the second quarter, consolidated revenue was $1.16 billion, up 3% year-over-year...
Intra-Cellular Therapies has an analyst consensus of Strong Buy, with a price target consensus of $95.31, representing a 25.3% upside. In a report issued on June 12, J.P. Morgan also maintained a Buy rating on the stock with a $78.00 price target. See today’...
Illumina, Inc. Stock price in December 2024 Illumina, Inc. stock is traded under the ticker #ILMN. Below you can review Illumina, Inc. stock performance in the past 12 months up to December 2024Total visits to Illumina, Inc.'s top domains Understand Illumina, Inc. market share and potentia...
Stock Price$136.22 Change1.08% Volume1,363,470 Illumina, Inc. is developer, manufacturer and marketer of integrated systems for the large scale analysis of genetic variation and biological function. Request Video of ILMN Already a member?